I refer to ST article “Temasek increases stake in US-based pharma firm” by Jeremy Koh. (27 Jan)
ST: “Temasek Holdings lifted its shareholding in Nasdaq-listed Portola Pharmaceuticals last year “.. “increased its holding by 750,000 shares over the course of last year to 6.584 million, ..”
During the first 3 quarters, there was no change in Temasek’s holding of 5,833,568 shares. ST should have stated this factually: Temasek increased its holding in Q4 2015 instead of over the course of last year.
What’s really strange – Temasek subsequently divested its entire holding in Portola in the same quarter it had invested an additional S$50 million.
According to NASDAQ, Temasek had sold all its listed US investments except Level 3 Communications Inc. link